Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: Estimation in a French web-based cohort

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 3, 2014, Pages 536-543

  Debin, Marion ^a,b   Colizza, Vittoria ^a,b,c   Blanchon, Thierry ^a,b   Hanslik, Thomas ^a,b,d,e   Turbelin, Clement ^a,b   Falchi, Alessandra ^a,f  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ISI FOUNDATION   (Italy)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

^f UNIVERSITÉ DE CORSE   (France)

Author keywords

General population; GrippeNet; Influenza; Vaccine; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEASONAL INFLUENZA; ADOLESCENT; ADULT; AGED; CHILD; EPIDEMIOLOGICAL MONITORING; FRANCE; IMMUNOLOGY; INCIDENCE; INFANT; INFLUENZA, HUMAN; INTERNET; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNET; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898428987     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27439     Document Type: Article

References (54)

1. Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H. [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med 2012; 41:e568-76; PMID:22795870; http://dx.doi.org/10.1016/j.lpm.2012.05.017
2. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31; PMID:17403908; http://dx.doi.org/10.1093/ije/dym021
3. Valenciano M, Kissling E; I-MOVE Case-Control Study Team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013; 18:3; PMID:23449183
4. Falchi A, Souty C, Grisoni ML, Mosnier A, Hanslik T, Daviaud I, Varesi L, Kerneis S, Carrat F, Blanchon T. Field seasonal influenza vaccine effectiveness: Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season. Hum Vaccin Immunother 2013; 9:9; PMID:23811610; http://dx.doi.org/10.4161/hv.25513
5. Eames KT, Brooks-Pollock E, Paolotti D, Perosa M, Gioannini C, Edmunds WJ. Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort. Epidemiol Infect 2012; 140:1309-15; PMID:21906412; http://dx.doi.org/10.1017/S0950268811001804
6. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40; PMID:15367555; http://dx.doi.org/10.1001/jama.292.11.1333
7. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170:650-6; PMID:19625341; http://dx.doi.org/10.1093/aje/kwp173
8. Brooks-Pollock E, Tilston N, Edmunds WJ, Eames KT. Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis 2011; 11:68; PMID:21410965; http://dx.doi.org/10.1186/1471-2334-11-68
9. Friesema IHM, Koppeschaar CE, Donker GA, Dijkstra F, van Noort SP, Smallenburg R, van der Hoek W, van der Sande MAB. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine 2009; 27:6353-7; PMID:19840672; http://dx.doi.org/10.1016/j.vaccine.2009.05.042
10. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 1999; 28:283-90; PMID:10064245; http://dx.doi.org/10.1086/515117
11. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67; PMID:19086915; http://dx.doi.org/10.1086/595861
12. McMenamin J, Andrews N, Robertson C, Fleming D, Durnall H, von Wissmann B, Ellis J, Lackenby A, Cottrell S, Smyth B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill 2013; 18:18; PMID:23399421
13. Belchior E [Bull Epidemiol Hebd] N. Surveillance épidé miologique, clinique et virologique de la grippe en France mé tropolitaine: saison 2012-2013. [Bull Epidemiol Hebd]; 32.
14. Fantoni A, Arena C, Corrias L, Salez N, de Lamballerie XN, Amoros JP, Blanchon T, Varesi L, Falchi A. Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France. J Med Virol 2013; (Forthcoming) PMID:24105757; http://dx.doi.org/10.1002/jmv.23745
15. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, Sabaiduc S, Gubbay JB, Charest H, Petric M, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill 2013; 18:18; PMID:23399422
16. Kelvin DJ, Farooqui A. Extremely low vaccine effectiveness against influenza H3N2 in the elderly during the 2012/2013 flu season. J Infect Dev Ctries 2013; 7:299-301; PMID: 23493013; http://dx.doi.org/10.3855/jidc.3544
17. Fu C, He Q, Li Z, Xu J, Li Y, Lu J, Li K, Yang Q, Dong Z, Liu X, et al. Seasonal influenza vaccine effectiveness among children, 2010-2012. Influenza Other Respir Viruses 2013; 7:1168-74; PMID:23981250; http://dx.doi.org/10.1111/ irv.12157
18. He Q, Xu J, Chen X, Lu J, Li K, Li Z, Wang M, Yang Q, Dong Z, Liu X, et al. Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over 2 consecutive seasons in children in Guangzhou, China: a matched case-control study. Hum Vaccin Immunother 2013; 9:1720-4; PMID:23733038; http://dx.doi.org/10.4161/hv.24980
19. Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis 2013; 207:1262-9; PMID:23341536; http://dx.doi.org/10.1093/infdis/jit020
20. Englund H, Campe H, Hautmann W. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2013; 141:1807-15; PMID:23098364; http://dx.doi.org/10. 1017/S0950268812002282
21. Pitigoi D, Ivanciuc AE, Necula G, Lupulescu E, Alexandrescu V, Savulescu C. Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010-2011 in Romania: a case control study. Revista Româna de Laborator 2012; 20:127-34
22. Coleman LA, Kieke B, Irving S, Shay DK, Vandermause M, Lindstrom S, Belongia EA. Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Vaccine 2011; 29:387-90; PMID:21095253; http://dx.doi.org/ 10.1016/j.vaccine.2010.10.082
23. Herrera GA, Iwane MK, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves SS, Gargiullo P, Bridges CB. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007; 25:154-60; PMID:17064823; http://dx.doi.org/10.1016/j.vaccine. 2006.05.129
24. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133-8; PMID:15163501; http://dx.doi.org/10.1016/j.virusres.2004.02.025
25. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; CD004876; PMID:20166072
26. Williams CJ, Schweiger B, Diner G, Gerlach F, Haaman F, Krause G, Nienhaus A, Buchholz U. Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07. BMC Infect Dis 2010; 10:8; PMID:20067628; http://dx.doi.org/10.1186/1471-2334-10-8
27. Castilla J, Godoy P, Domínguez Á, Martín V, Delgado-Rodríguez M, Martínez-Baz I, Baricot M, Soldevila N, Mayoral JM, Astray J, et al.; CIBERESP Cases and Controls in Influenza Working Group. Risk factors and effectiveness of preventive measures against influenza in the community. Influenza Other Respir Viruses 2013; 7:177-83; PMID:22458533; http://dx.doi.org/10.1111/j.1750-2659.2012.00361.x
28. Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121:811-22; PMID:4014174
29. Meier CR, Napalkov PN, Wegmüller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19:834-42; PMID:11152308; http://dx.doi.org/10.1007/ s100960000376
30. Smolderen KGE, Vingerhoets AJJM, Croon MA, Denollet J. Personality, psychological stress, and self-reported influenza symptomatology. BMC Public Health 2007; 7:339; PMID:18036207; http://dx.doi.org/10.1186/1471-2458-7-339
31. Gordon A, Ortega O, Kuan G, Reingold A, Saborio S, Balmaseda A, Harris E. Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis 2009; 15:408-14; PMID:19239753; http://dx.doi.org/ 10.3201/eid1503.080238
32. Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011; 6:e19621; PMID:21573005; http://dx.doi.org/10.1371/journal.pone.0019621
33. Nichol KL, Korn JE, Baum P. Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire. Am J Prev Med 1991; 7:199-203; PMID:1756055
34. Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999; 16:173-7; PMID:10198654; http://dx.doi.org/10.1016/S0749-3797(98) 00159-7
35. Orts K, Sheridan JF, Robinson-Whelen S, Glaser R, Malarkey WB, Kiecolt-Glaser JK. The reliability and validity of a structured interview for the assessment of infectious illness symptoms. J Behav Med 1995; 18:517-29; PMID:8749983; http://dx.doi.org/10.1007/BF01857893
36. Keck JW, Redd JT, Cheek JE, Layne LJ, Groom AV, Kitka S, Bruce MG, Suryaprasad A, Amerson NL, Cullen T, et al. Influenza surveillance using electronic health records in the American Indian and Alaska Native population. J Am Med Inform Assoc 2014; 21:132-8; PMID:23744788; http://dx.doi.org/10.1136/ amiajnl-2012-001591
37. Tilston NL, Eames KT, Paolotti D, Ealden T, Edmunds WJ. Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 2010; 10:650; PMID:20979640; http://dx.doi.org/10. 1186/1471-2458-10-650
38. Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2012; 30:995-7; PMID:22178520; http://dx.doi.org/10.1016/j. vaccine.2011.12.011
39. Ebell MH, Afonso A. A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med 2011; 9:69-77; PMID:21242564; http://dx.doi.org/10.1370/afm.1192
40. Cooper DL, Smith GE, Chinemana F, Joseph C, Loveridge P, Sebastionpillai P, Gerard E, Zambon M. Linking syndromic surveillance with virological self-sampling. Epidemiol Infect 2008; 136:222-4; PMID:17394678; http://dx.doi.org/10.1017/S0950268807008412
41. Influenzanet. 2013.
42. Debin M, Turbelin C, Blanchon T, Bonmarin I, Falchi A, Hanslik T, Levy-Bruhl D, Poletto C, Colizza V. Evaluating the feasibility and participants' representativeness of an online nationwide surveillance system for influenza in France. PLoS One 2013; 8:e73675; PMID:24040020; http://dx.doi.org/10.1371/ journal.pone.0073675
43. Vandendijck Y, Faes C, Hens N. Eight years of the Great Influenza Survey to monitor influenza-like illness in Flanders. PLoS One 2013; 8:e64156; PMID:23691162; http://dx.doi.org/10.1371/journal.pone.0064156
44. van Noort SP, Muehlen M, Rebelo de Andrade H, Koppeschaar C, Lima Lourenço JM, Gomes MG. Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe. Euro Surveill 2007; 12:E5-6; PMID:17991409
45. Valleron AJ, Bouvet E, Garnerin P, Ménarès J, Heard I, Letrait S, Lefaucheux J. A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 1986; 76:1289-92; PMID:3766824; http://dx.doi.org/10.2105/AJPH.76.11.1289
46. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep 1963; 78:494-506; PMID:19316455; http://dx.doi.org/10.2307/4591848
47. World Health Organization. FluNet. 2013. Available from: http://www.who.int/influenza/gisrs-laboratory/flunet/en/
48. Institut national de la statistique et des études économiques. Les estimations de population. 2013.
49. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, Miller E, Zambon M. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010; 64:1062-7; PMID:19910645; http://dx.doi.org/10.1136/jech.2009.093450
50. Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A; cycEVA Study Team; Spanish Influenza Sentinel Surveillance System. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012; 30:3595-602; PMID:22472792; http://dx.doi.org/10.1016/j.vaccine.2012.03.048
51. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280:1690-1; PMID: 9832001; http://dx.doi.org/10.1001/jama.280.19.1690
52. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157:940-3; PMID:12746247; http://dx.doi.org/10.1093/aje/kwg074
53. Knol MJ, Le Cessie S, Algra A, Vandenbroucke JP, Groenwold RH. Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ 2012; 184:895-9; PMID:22158397; http://dx.doi.org/10.1503/cmaj.101715
54. R Development Core Team. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available from: http://www.R-project.org/. 2011.